桥本甲状腺炎合并非内分泌自身免疫性疾病女性的复发性妊娠丢失
该回顾性观察性队列研究在3480例连续检查的桥本甲状腺炎(HT)女性中,87例符合复发性妊娠丢失(RPL)标准,其中65例为孤立性HT,22例合并非内分泌自身免疫性疾病(NEAD)。HT+NEAD组RPL率为5.64%,孤立性HT组为2.1%(OR=2.78,95%CI 1.70-4.57,p<0.0001);甲状腺功能正常者中差异仍显著(p<0.0001),甲状腺功能减退者中差异消失(p=0.21)。抗磷脂综合征仅解释HT+NEAD组3/22(14%)的RPL。
要点
- HT+NEAD组RPL率5.64% vs 孤立性HT组2.1%(OR=2.78,95%CI 1.70-4.57,p<0.0001)。
- 甲状腺功能正常者中两组RPL差异仍显著(p<0.0001),甲状腺功能减退者中差异消失(p=0.21)。
- RPL与自身抗体浓度无关,抗磷脂综合征仅解释HT+NEAD组3/22(14%)的RPL。
核心结论
- NEAD共存与HT女性更高的RPL风险相关,抗磷脂综合征可能仅解释多重自身免疫患者RPL率的一部分。
研究设计与样本
- 回顾性观察性队列研究,在大学医院内分泌门诊连续检查3480例HT女性,87例符合RPL标准(孤立性HT 65例,HT+NEAD 22例),并对HT合并NEAD进行系统综述。
主要发现
- HT+NEAD组RPL率为5.64%,孤立性HT组为2.1%(OR=2.78,95%CI 1.70-4.57,p<0.0001)。
- 甲状腺功能正常者中两组RPL差异仍显著(p<0.0001),甲状腺功能减退者中差异消失(p=0.21)。
- RPL与自身抗体浓度无关,无论孤立性HT还是HT+NEAD。
- 抗磷脂综合征解释HT+NEAD组3/22(14%)的RPL,其余与不同自身免疫性疾病相关。
- 剔除抗磷脂综合征患者后,多重自身免疫者RPL仍比孤立性HT者更常见(p=0.0013)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: An increased rate of recurrent miscarriage has been described in patients with autoimmune thyroid disease. However, there is a lack of studies that assess the rate of recurrent pregnancy loss (RPL) in patients with Hashimoto's thyroiditis (HT) isolated or with concurrent non-endocrine autoimmune disorders (NEAD). The objective of the study was to assess the rate of RPL in patients with HT isolated or accompanied with non-endocrine autoimmune diseases. Methods: This is a retrospective observational cohort study with a systematic review of the NEAD with concurrent HT in an outpatient Endocrinology Unit at a University Hospital. Among the 3480 consecutively examined women with HT, 87 patients met the criteria of RPL and represented the study group. Sixty-five of them had isolated HT and 22 women had HT+NEAD. Results: The rate of RPL in women with HT was 2.1% versus 5.64% observed in women with HT+NEAD (odds ratio = 2.78 [95% confidence interval 1.70-4.57]; p < 0.0001). On subdivision, this difference was still evident in euthyroid patients (p < 0.0001), while it disappeared in hypothyroid women (p = 0.21). The RPL did not correlate with the autoantibody concentrations nor in women with isolated HT nor in those with HT+NEAD. The presence of antiphospholipid syndrome (APS) explained RPL in 3 out of 22 (14%) patients with HT+NEAD, the remaining being related to different autoimmune disorders. Interestingly, even subtracting the patients with APS, RPL was more frequent in patients with poly-autoimmunity than in patients with isolated HT (p = 0.0013). Conclusions: The co-presence of NEAD is correlated with a higher risk of RPL in women with HT. The association with APS may explain only a fraction of RPL rate in patients with poly-autoimmunity.
引用
- Cellini M, Santaguida MG, Stramazzo I, et al. Recurrent Pregnancy Loss in Women with Hashimoto's Thyroiditis with Concurrent Non-Endocrine Autoimmune Disorders. Thyroid. 2020. PMID: 31910128. doi:10.1089/thy.2019.0456
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。